Bipolar disorders treatment market analysis | Coherent Market Insights - PowerPoint PPT Presentation

About This Presentation

Bipolar disorders treatment market analysis | Coherent Market Insights


Read here the latest updates on the Bipolar disorders treatment market analysis published by the CMI team. – PowerPoint PPT presentation

Number of Views:40


Transcript and Presenter's Notes

Title: Bipolar disorders treatment market analysis | Coherent Market Insights

Coherent Marketing Insights
  • Market Research Business Consulting Services
  • https//
  • Covid-19 Impact Tracker

  • Bipolar Disorder Treatment Market, By Drug Class
    (Antipsychotics, Antidepressants, Mood
    Stabilizers, and Anti-anxiety Drugs and Others),
    By Distribution Channel (Hospital Pharmacies,
    Retail Pharmacies, and Online Pharmacies), and by
    Region (North America, Latin America, Europe,
    Asia Pacific, Middle East, and Africa) - Size,
    Share, Outlook, and Opportunity Analysis, 2019 -

  • Bipolar disorder, also known as manic illness, is
    a brain disorder that affects the mood, energy
    level, and other activities. This disorder
    consists of various episodes, and major among
    these are manic and depression. There is a
    sudden change in mood of the patient and his/her
    ability to carry out daily tasks. There are four
    types of bipolar disorders bipolar I, bipolar
    II, cyclothymic, and other specified and
    non-specified bipolar and related disorders.
  • The people suffering from bipolar disorder
    experience periods of unusually intense emotion,
    irregular sleep patterns and activity levels, and
    mood episodes. Bipolar disorder is diagnosed
    based on the patients symptoms, family history,
    and lifetime history. The healthcare provider
    generally conducts a mental health evaluation for
    the diagnosis of bipolar disorder.
  • The global bipolar disorder treatment market size
    is estimated to be valued at US 7,288.3 million
    in 2019 and is expected to exhibit a CAGR of 5.2
    over the forecast period (2019-2027).

  • Figure 1. Global Bipolar Disorder Treatment
    Market Value (US Mn), by Region, 2019

  • Increasing product approvals and launches are
    expected to propel the market growth over the
    forecast period
  • Key players are focusing on enhancing their
    product portfolio through increasing launches and
    approvals of new drugs for the treatment of
    bipolar disorder, which is expected to drive
    growth of the bipolar disorder treatment market
    over the forecast period. For instance, in May
    2019, Allergan plc and Gedeon Richter Plc.
    received the U.S. Food and Drug Administration
    (FDA) approval for its supplemental new drug
    application (sNDA) of VRAYLAR (cariprazine),
    anoral, once daily atypical antipsychotic drug
    for expanded use and treatment of depressive
    episodes associated with bipolar I disorder
    (bipolar depression) in adults.
  • Moreover, in May 2016, Procera Health announced
    the launch of ProceraMood, a non-prescription
    drug, which offers mood stabilization, and
    supporting balance and calmness.

Figure 2. Global Bipolar Disorder Treatment
Market Share (), by Drug Class, 2019 and 2027

Increasing mergers, agreements, and
collaborations to develop treatment for bipolar
disorder is expected to drive the market growth
over the forecast period
  • Market players are focused on adoption of
    inorganic growth strategies such as
    collaborations and partnerships to strengthen
    their position in the bipolar disorder treatment
    market. For instance, in November 2017, Sumitomo
    Dainippon Pharma Co., Ltd and Angelini S.p.A
    entered into a strategic partnership in order to
    distribute and commercialize Latuda (Lurasidone
    Hydrochloride), developed by Sumitomo Dainippon
    Pharma, in the European market (29 European
    countries and in Turkey). Under this agreement, a
    subsidiary company of Sumitomo Dainippon Pharma
    Group (Sunovion Pharmaceuticals Europe Ltd.)
    granted rights to Angelini for distribution and
    commercialization of LATUDA in European Market.
  • However, side effects associated with drugs used
    in the treatment of bipolar disorder is expected
    to be a factor negatively affecting growth of the
    market up to certain extent, as patients hesitate
    to undergo medication therapy due to fear of the
    same. For instance, some of the medications
    including carbamazepine, Divalproex sodium, and
    Lithium used in the treatment of bipolar disorder
    have some side effects such as nausea, tremors,
    sexual problem, impaired memory, muscle weakness,
    decreased thyroid function, liver and kidney
    damage, skin reactions, and others.

Key Players
  • Major players operating in the global bipolar
    disorder treatment market include Takeda
    Pharmaceutical Company Limited, Pfizer, Inc.,
    Allergan plc, Otsuka Holdings Co. Ltd., Johnson
    Johnson, Eli Lilly and Company, GlaxoSmithKline
    plc, AstraZeneca Plc, Novartis International AG,
    AbbVie Inc., H. Lundbeck A/S, Minerva
    Neurosciences, Sumitomo Dainippon Pharma Co.,
    Ltd., Intra-Cellular Therapies Inc., Gedeon
    Richter Plc., and Indivior PLC.

  • Request Sample Report
  • Request Customization
  • Download PDF Brochure
  • Talk to Analyst
  • Referance https//

About Us
  • Coherent Market Insights is a global market
    intelligence and consulting organization focused
    on assisting our plethora of clients achieve
    transformational growth by helping them make
    critical business decisions. We are headquartered
    in India, having office at global financial
    capital in the U.S. Our client base includes
    players from across all business verticals in
    over 150 countries worldwide.
  • What We ProvideCustomized Market Research
    AnalysisIndustry Analysis ServicesBusiness
    Consulting ServicesLong Term Engagement
    ModelCountry Specific Analysis

Contact Us
  • Mr. Shah
  • Coherent Market Insights Pvt. LTD.Coherent
    Market Insights 1001 4th Ave, 3200 Seattle, WA
    98154, U.S.Phone 1-206-701-6702
  • Email

Thank You
  • Kindly Follow CMI Social Media Profiles for the
    latest Company Updates.
  • Facebook
  • Linkedin
  • Twitter
  • https//
Write a Comment
User Comments (0)